<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-106374</identifier>
<setSpec>1575-0922</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">New prospects for drug treatment in Cushing disease</dc:title>
<dc:description xml:lang="en">Hypercortisolism induced by Cushing disease causes high morbidity and mortality.The treatment of choice is pituitary surgery, but it often fails to achieve cure, and othertreatment modalities (radiotherapy, bilateral adrenalectomy) may therefore be required. Ifthese treatments are not effective or while waiting for their results, hypercortisolism shouldbe controlled with drugs.The classical drug treatments are those that act by inhibiting cortisol secretion by the adrenalgland (ketoconazole, metyrapone, mitotane, etomidate). The preliminary results of a new drug (LCI699) which is a potent enzyme inhibitor of cortisolsecretion have been reported.A clinical trial of the safety and ef&amp;#64257;cacy of mifepristone, a glucocorticoid receptor antagonist,has just been published.The drugs deserving more attention today are those with a direct action on the tumor by inhibiting ACTH secretion: somatostatin analogues (pasireotide), dopamine agonists (cabergoline),PPAR- , and retinoic acid.A special review is made of the available clinical trials with pasireotide and cabergoline (AU)</dc:description>
<dc:creator>Barahona Constanzo, Maria-Jose</dc:creator>
<dc:creator>del Pozo Pico, Carlos</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los farmacos que en la actualidad estan mereciendo mas atencion son aquellos con accion directa sobre el tumor inhibiendo la secrecion de ACTH: analogos de la somatostatina (..)  (AU)</dc:description>
<dc:source>Endocrinol Nutr;59(10): 599-605, dic. 2012.</dc:source>
<dc:identifier>ibc-106374</dc:identifier>
<dc:title xml:lang="es">Nuevas perspectivas en el tratamiento farmacologico de la enfermedad de Cushing</dc:title>
<dc:subject>^d6082^s22006</dc:subject>
<dc:subject>^d38634^s22057</dc:subject>
<dc:subject>^d22676^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d23620^s22073</dc:subject>
<dc:subject>^d31706^s22006</dc:subject>
<dc:subject>^d311^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201212</dc:date>
</metadata>
</record>
</ibecs-document>
